Table 1 Clinicopathologic features and expression of TFPI-2
From: Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer
TFPI-2 negative No.(%) | TFPI-2 positive N0.(%) | χ2 | P value | |
|---|---|---|---|---|
Age | ||||
≤55 | 24(68.6%) | 74(61.2%) | 0.639 | 0.424 |
>55 | 11(31.4%) | 47(38.8%) | ||
Tumor size | ||||
≤2 cm | 12(34.3%) | 56(46.3%) | 1.589 | 0.208 |
>2 cm | 23(65.7%) | 65(53.7%) | ||
Skin involvementa | ||||
No | 30(85.7%) | 96(79.3%) | 0.710 | 0.399 |
Yes | 5(14.3%) | 25(20.7%) | ||
LN metastasis | ||||
No | 9(26.5%) | 70(58.3%) | 10.766 | 0.001 |
Yes | 25(73.5%) | 50(41.7%) | ||
Unknown | 1 | 1 | ||
Histologic grade | ||||
≤II | 13(37.1%) | 71(58.7%) | 5.066 | 0.024 |
>II | 22(62.9%) | 50(41.3%) | ||
Vessel invasion | ||||
Absence | 12(35.3%) | 109(90.0%) | 46.528 | 0.001 |
Presence | 22(64.7%) | 12(10.0%) | ||
Unknown | 1 | 0 | ||
Clinical stage | ||||
I | 5(14.3%) | 35(28.9%) | 4.809 | 0.090 |
II | 22(62.9%) | 52(43.0%) | ||
III | 8(22.9%) | 34(28.1%) | ||
ER | ||||
(-) | 12(35.3%) | 43(35.8%) | 0.003 | 0.954 |
(+) | 22(64.7%) | 77(64.2%) | ||
Unknown | 1 | 1 | ||
PR | ||||
(-) | 15(44.1%) | 63(52.5%) | 0.745 | 0.388 |
(+) | 19(55.9%) | 57(47.5%) | ||
Unknown | 1 | 1 | ||
HER-2 | ||||
(-) | 17(50.0%) | 62(53.0%) | 0.095 | 0.759 |
(+) | 17(50.0%) | 55(47.0%) | ||
Unknown | 1 | 4 | ||
Tumor type | ||||
IDCb | 29(82.9%) | 98(81.0%) | 0.062 | 0.803 |
Non-IDCc | 6(17.1%) | 23(19.0%) |